The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
State-dependent opioid control of pain
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The high concentration of opioid receptors expressed in rACC (Vogt et al., 1993; Fields, 2004) has been hypothesized to relate to attentional mechanisms that can suppress pain processing (Petrovic et al., 2002), a suggestion that has received experimental support (Zubieta et al., 2005; Wager et al., 2007; Eippert et al., 2009).”
From Top-Down Dysregulation—From ADHD to Emotional Instability (2016) · cites this paper as Fields, 2004
Citations
Cites
Molecular mechanisms of nociception
Julius, D., & Basbaum, A. I. (2001) · Nature · doi:10.1038/35093019 · Cited by 2,685 · cited 1×
“We now know a great deal about the molecular mechanisms of transduction and the relationship of the firing of these neurons to stimulus intensity and to the psychophysics of perceived pain intensit”
BackgroundTHE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
Self-citationOrganization of endogenous opiate and nonopiate pain control systems
Watkins, L. R., & Mayer, D. J. (1982) · Science · doi:10.1126/science.6281891 · Cited by 791
Response expectancies in placebo analgesia and their clinical relevance
Pollo, A., Amanzio, M., Arslanian, A., Casadio, C., Maggi, G., & Benedetti, F. (2001) · Pain · doi:10.1016/s0304-3959(01)00296-2 · Cited by 442
Liebeskind, J. C., Guilbaud, G., Besson, J.-M., & Oliveras, J.-L. (1973) · Brain Research · doi:10.1016/0006-8993(73)90748-8 · Cited by 439
The role of conditioning and verbal expectancy in the placebo response
Voudouris, N. J., Peck, C. L., & Coleman, G. (1990) · Pain · doi:10.1016/0304-3959(90)90057-k · Cited by 369
Sucrose ingestion causes opioid analgesia.
Segato, F. N., Castro-Souza, C., Segato, E. N., Morato, S., & Coimbra, N. C. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997000800011 · Cited by 72
Flagged first, then by citations
Research works printed but not linked: 128
- Melzack, R. & Wall, P. D. Acute pain in an emergency clinic: latency of onset and descriptor patterns related to different injuries. Pain 14, 33–43 (1982). · DOI
- Akil, H. et al. Endogenous opioids: overview and current issues. Drug Alcohol Depend. 51, 127–140 (1998). · DOI
- Kieffer, B. L. & Gaveriaux-Ruff, C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66, 285–306 (2002). · DOI · Paper page
- Fields, H. L., Heinricher, M. M. & Mason, P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14, 219–245 (1991). · DOI
- Yaksh, T. L. & Rudy, T. A. Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain 4, 299–359 (1978). This is a thorough review of the initial mapping studies of CNS sites that are sensitive to the analgesic effect of opioids. · DOI
- Heinricher, M. M. & McGaraughty, S. in State-Dependent Processing in Somatosensory Pathways (ed. Soja, P. J.) 487–503 (CRC Press, San Diego, 1998).
- Fields, H. L. & Basbaum, A. I. in Textbook of Pain (eds Wall, P. D. & Melzack, R.) 309–329 (Churchill Livingstone, Edinburgh, 1999).
- Neubert, M. J., Kincaid, W. & Heinricher, M. M. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain (in the press). By selectively activating on cells, the authors provide definitive evidence that these cells facilitate nociceptive transmission. · DOI
- Ackley, M. A., Hurley, R. W., Virnich, D. E. & Hammond, D. L. A cellular mechanism for the antinociceptive effect of a κ-opioid receptor agonist. Pain 91, 377–388 (2001). The authors demonstrate presynaptic control of glutamatergic inputs by KOR agonists in vitro. · DOI
- Chieng, B. & Christie, M. J. Hyperpolarization by opioids acting on μ-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br. J. Pharmacol. 113, 121–128 (1994). · DOI
- Pan, Z. Z., Tershner, S. A. & Fields, H. L. Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor. Nature 389, 382–385 (1997). · DOI
- Price, D. D. Psychological Mechanisms of Pain and Analgesia (IASP Press, Seattle, 1999). A classic book in which the author presents a thorough review of the psychophysics of pain, and of the cognitive and experiential modifiers of pain. He puts this perceptual evidence into a neurobiological and clinical perspective.
- Willis, W. D. & Coggeshall, R. E. Sensory Mechanisms of the Spinal Cord (Plenum, New York, 1991). · DOI
- Wall, P. D. & Melzack, R. (eds) Textbook of Pain (Churchill Livingstone, Edinburgh, 1999).
- Casey, K. L. & Bushnell, M. C. (eds) Pain Imaging (IASP Press, Seattle, 2000).
- Wall, P. D. The laminar organisation of dorsal horn and effects of descending impulses. J. Physiol. (Lond.) 188, 403–423 (1967). This is a seminal description of dorsal horn neurons as feature detectors with response properties that are subject to top–down modulation. Wall demonstrated that each dorsal horn lamina contained neurons with distinct physiological properties, and he placed the main focus of pain research on the spinal cord. · DOI
- Reynolds, D. V. Surgery in the rat during electrical analgesia by focal brain stimulation. Science 164, 444–445 (1969). The original description of stimulation-produced analgesia in rodents. · DOI
- Mayer, D. J., Wolfe, T. L., Akil, H., Carder, B. & Liebeskind, J. C. Analgesia from electrical stimulation in the brain stem of the rat. Science 174, 1351–1354 (1971). · DOI
- Mayer, D. J. & Liebeskind, J. C. Pain reduction by focal stimulation of the brain: an anatomical and behavioural analysis. Brain Res. 68, 73–93 (1974). · DOI
- Hosobuchi, Y., Adams, J. E. & Linchitz, R. Pain relief by electrical stimulation of the central gray matter in humans in its reversal by naloxone. Science 197, 183–186 (1977). · DOI
- Baskin, D. S. et al. Autopsy analysis of the safety, efficacy and cartography of electrical stimulation of the central gray in humans. Brain Res. 371, 231–236 (1986). · DOI
- Holden, J. E., van Poppel, A. Y. & Thomas, S. Antinociception from lateral hypothalamic stimulation may be mediated by NK1 receptors in the A7 catecholamine cell group in rat. Brain Res. 953, 195–204 (2002). · DOI
- Stein, C., Schafer, M. & Machelska, H. Attacking pain at its source: new perspectives on opioids. Nature Med. 9, 1003–1008 (2003). · DOI
- Grudt, T. J. & Williams, J. T. μ-opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat. J. Neurosci. 14, 1646–1654 (1994). · DOI
- Glaum, S. R., Miller, R. J. & Hammond, D. L. Inhibitory actions of δ1, δ2, and μ-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J. Neurosci. 14, 4965–4971 (1994). This study demonstrates both pre- and postsynaptic actions of opioids at the first relay from primary afferent nociceptors to second-order dorsal horn neurons. · DOI
- Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H. & Watson, S. J. Anatomy of CNS opioid receptors. Trends Neurosci. 11, 308–314 (1988). · DOI
- Mansour, A., Fox, C. A. & Watson, S. J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22–29 (1995). A concise survey of MOR, KOR and DOR distribution in the CNS. · DOI
- Arvidsson, U. et al. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15, 3328–3341 (1995). · DOI
- Manning, B. H., Morgan, M. J. & Franklin, K. B. J. Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. Neuroscience 63, 289–294 (1994). · DOI
- Burkey, A. R., Carstens, E., Wenniger, J. J., Tang, J. & Jasmin, L. An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat that contributes to morphine antinociception. J. Neurosci. 16, 6612–6623 (1996). · DOI
- Tershner, S. A. & Helmstetter, F. J. Antinociception produced by μ-opioid receptor activation in the amygdala is partly dependent on activation of μ-opioid and neurotensin receptors in the ventral periaqueductal gray. Brain Res. 865, 17–26 (2000). · DOI
- Kiefel, J. M., Rossi, G. C. & Bodnar, R. J. Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624, 151–161 (1993). · DOI
- Roychowdhury, S. M. & Fields, H. L. Endogenous opioids acting at a medullary μ-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray. Neuroscience 74, 863–872 (1996). · DOI
- Al-Rodhan, N., Chipkin, R. & Yaksh, T. L. The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal, ventral medulla and amygdala. Brain Res. 520, 123–130 (1990). · DOI
- Watkins, L. R., Young, E. G., Kinscheck, I. B. & Mayer, J. D. The neural basis of footshock analgesia: the role of specific ventral medullary nuclei. Brain Res. 276, 305–315 (1983). · DOI
- Levine, J. D., Gordon, N. C., Jones, R. T. & Fields, H. L. The narcotic antagonist naloxone enhances clinical pain. Nature 272, 826–827 (1978). The first direct evidence that endogenous opioids modulate pain in humans. The authors used dental postoperative pain as the measure of action of the opioid-mediated analgesia system. · DOI
- Fields, H. L. Is there a facilitating component to central pain modulation? APS J. 1, 139–141 (1992). · DOI
- Porreca, F., Ossipov, M. H. & Gebhart, G. F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319–325 (2002). · DOI · Paper page
- Urban, M. O. & Gebhart, G. F. Supraspinal contributions to hyperalgesia. Proc. Natl Acad. Sci. USA 96, 7687–7692 (1999). · DOI
- Zhuo, M. & Gebhart, G. F. Characterization of descending inhibition and facilitation from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Pain 42, 337–350 (1990). · DOI
- Zhuo, M. & Gebhart, G. F. Characterization of descending facilitation and inhibition of spinal nociceptive transmission from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. J. Neurophys. 67, 1599–1614 (1992). · DOI
- Urban, M. O., Coutinho, S. V. & Gebhart, G. F. Biphasic modulation of visceral nociception by neurotensin in rat rostral ventromedial medulla. J. Pharmacol. Exp. Ther. 290, 207–213 (1999).
- Watkins, L. R. et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639, 283–299 (1994). · DOI
- Morgan, M. M., Heinricher, M. M. & Fields, H. L. Inhibition and facilitation of different nocifensor reflexes by spatially remote noxious thermal stimuli. J. Neurophysiol. 72, 1152–1160 (1994). · DOI
- Haws, C. M., Williamson, A. M. & Fields, H. L. Putative nociceptive modulatory neurons in the dorsolateral pontomesencephalic reticular formation. Brain Res. 483, 272–282 (1989). · DOI
- Heinricher, M. M., Cheng, Z. F. & Fields, H. L. Evidence for two classes of nociceptive modulating neurons in the periaqueductal gray. J. Neurosci. 7, 271–278 (1987). · DOI
- Fields, H. L., Malick, A. & Burstein, R. Dorsal horn projection targets of on and off cells in the rostral ventromedial medulla. J. Neurophysiol. 74, 1742–1759 (1995). Microstimulation is used to track the terminals of on and off cells into dorsal horn laminae I, II and V. · DOI
- Heinricher, M. M., McGaraughty, S. & Farr, D. A. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 81, 57–65 (1999). · DOI
- Heinricher, M. M., McGaraughty, S. & Grandy, D. K. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J. Neurophysiol. 78, 3351–3358 (1997). · DOI
- Heinricher, M. M., McGaraughty, S. & Tortorici, V. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J. Neurophysiol. 85, 280–286 (2001). · DOI
- Morgan, M. M. & Fields, H. L. Pronounced changes in the activity of nociceptive modulatory neurons in the rostral ventromedial medulla in response to prolonged thermal noxious stimuli. J. Neurophysiol. 72, 1161–1170 (1994). · DOI
- Porreca, F. et al. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expression the μ-opioid receptor. J. Neurosci. 21, 5281–5288 (2001). · DOI
- Gardell, L. R. et al. Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. J. Neurosci. 23, 8370–8379 (2003). · DOI
- Barbaro, N. M., Heinricher, M. M. & Fields, H. L. Putative nociceptive modulatory neurons in the rostral ventromedial medulla of the rat display highly correlated firing patterns. Somatosens. Motor Res. 6, 413–425 (1989). · DOI
- Heinricher, M. M., Barbaro, N. M. & Fields, H. L. Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of on- and off-cells is related to nociceptive responsiveness. Somatosens. Motor Res. 6, 427–439 (1989). · DOI
- Heinricher, M. M. & McGaraughty, S. Analysis of excitatory amino acid transmission within the rostral ventromedial medulla: implications for circuitry. Pain 75, 247–255 (1998). · DOI
- Mason, P. Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annu. Rev. Neurosci. 24, 737–777 (2001). · DOI
- Leung, C. G. & Mason, P. Physiological properties of raphe magnus neurons during sleep and waking. J. Neurophysiol. 81, 584–595 (1999). This study uses single unit recording in awake rats to demonstrate state dependence of firing patterns in on, off and neutral cells in the rostral ventromedial medulla. · DOI
- Akil, H., Meng, F., Devine, D. P. & Watson, S. J. Molecular and neuroanatomical properties of the endogenous opioid system: implications tor treatment of opiate addiction. Semin. Neurosci. 9, 70–83 (1997). · DOI
- Eguchi, M. Recent advances in selective opioid receptor agonists and antagonists. Med. Res. Rev. 24, 182–212 (2004). · DOI
- Bridge, K. E., Wainwright, A., Reilly, K. & Oliver, K. R. Autoradiographic localization of 125i[tyr14] nociceptin/orphanin FQ binding sites in macaque primate CNS. Neuroscience 118, 513–523 (2003). · DOI
- Pan, Z. Z., Williams, J. T. & Osborne, P. B. Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J. Physiol. (Lond.) 427, 519–532 (1990). The first in vitro study of RVM neurons. The authors use sharp electrodes and demonstrate distinct populations of neurons that are either directly inhibited or disinhibited by opioid agonists. · DOI
- Heinricher, M. M., Morgan, M. M. & Fields, H. L. Direct and indirect action of morphine on medullary neurons that modulate nociception. Neuroscience 48, 533–543 (1992). · DOI
- Vaughan, C. W. & Christie, M. J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. (Lond.) 498, 463–472 (1997). · DOI
- Vaughan, C. W. et al. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br. J. Pharmacol. 139, 362–367 (2003). · DOI
- Heinricher, M. M., Morgan, M. M., Tortorici, V. & Fields, H. L. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 63, 279–288 (1994). · DOI
- Heinricher, M. M. & Tortorici, V. Interference with GABA transmission in the rostral ventromedial medulla: dishinhibition of off-cells as a central mechanism in nociceptive modulation. Neuroscience 63, 533–546 (1994). · DOI
- Finnegan, T. F., Li, D. P., Chen, S. R. & Pan, H. L. Activation of μ-opioid receptors inhibits synaptic inputs to spinally projecting rostral ventromedial medulla neurons. J. Pharmacol. Exp. Ther. 309, 476–483 (2004). · DOI
- Connor, M., Schuller, A., Pintar, J. E. & Christie, M. J. μ-Opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br. J. Pharmacol. 126, 1553–1558 (1999). · DOI
- Heinricher, M. M. & Fields, H. L. in The Delta Receptor: Molecular and Effect of Delta Opioid Compounds (ed. Woods, J.) 467–480 (Marcel Dekker, New York, 2003).
- Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. μ- and δ-opioid synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Research 665, 85–93 (1994). · DOI
- Ossipov, M. H., Kovelowski, C. J., Nichols, M. L., Hruby, V. J. & Porreca, F. Characterization of supraspinal antinociceptive actions of opioid δ agonists in the rat. Pain 62, 287–293 (1995). · DOI
- Connor, M. & Christie, M. J. Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J. Physiol. (Lond.) 509, 47–58 (1998). · DOI
- Kiefel, J. M., Rossi, G. C. & Bodnar, R. J. Medullary μ- and δ-opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624, 151–161 (1993). · DOI
- Hirakawa, N., Tershner, S. A. & Fields, H. L. Highly δ-selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO. Neuroreport 10, 3125–3129 (1999). · DOI
- Thorat, S. N. & Hammond, D. L. Modulation of nociception by microinjection of δ-1 and δ-2 opioid receptor ligands in the ventromedial medulla of the rat. J. Pharmacol. Exp. Ther. 283, 1185–1192 (1997).
- Harasawa, I., Fields, H. L. & Meng, I. D. δ-opioid receptor mediated actions in the rostral ventromedial medulla on tail flick latency and nociceptive modulatory neurons. Pain 85, 255–262 (2000). · DOI
- Cahill, C. M., Morinville, A., Hoffert, C., O'Donnell, D. & Beaudet, A. Up-regulation and trafficking of δ-opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101, 199–208 (2003). · DOI
- Hurley, R. W. & Hammond, D. L. The analgesic effects of supraspinal μ and δ opioid receptor agonists are potentiated during persistent inflammation. J. Neurosci. 20, 1249–1259 (2000). · DOI
- Vaughan, C. W., Ingram, S. L. & Christie, M. J. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17, 996–1003 (1997). References 84—86 demonstrate the robust and promiscuous inhibition that is produced by orphanin in both PAG and RVM. · DOI
- Pan, Z., Hirakawa, N. & Fields, H. L. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26, 515–522 (2000). · DOI
- Vaughan, C. W. et al. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. J. Physiol. (Lond.) 534, 849–859 (2001). · DOI
- Darland, T., Heinricher, M. M. & Grandy, D. K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21, 215–221 (1998). · DOI
- Millan, M. J. κ-opioid receptor-mediated antinociception in the rat. I. Comparative actions of μ- and κ-opioids against noxious, thermal, pressure and electrical stimuli. J. Pharmacol. Exp. Ther. 251, 334–341 (1989).
- Millan, M. J., Czlonkowski, A., Lipkowski, A. & Herz, A. κ-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. J. Pharmacol. Exp. Ther. 251, 342–350 (1989).
- Pan, Z. Z. μ-Opposing actions of the κ-opioid receptor. Trends Pharmacol. Sci. 19, 94–98 (1998). · DOI
- Bederson, J. B., Fields, H. L. & Barbaro, N. M. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased ON-cell activity in the rostral ventromedial medulla. Somatosens. Motor Res. 7, 185–203 (1990). · DOI
- Kaplan, H. & Fields, H. L. Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J. Neurosci. 11, 1433–1439 (1991). · DOI
- Bandler, R. & Keay, K. A. in Progress in Brain Research Vol. 107 (eds Holstege, G., Bandler, R. & Saper, C.) 285–300 (Elsevier, Amsterdam, 1996).
- Fanselow, M. S. Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress analgesia. Ann. NY Acad. Sci. 467, 40–54 (1986). · DOI · Paper page
- Bolles, R. C. & Fanselow, M. S. A perceptual-defensive-recuperative model of fear and pain. Behav. Brain Sci. 3, 291–323 (1980). · DOI
- Johansen, J. P., Fields, H. L. & Manning, B. H. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc. Natl Acad. Sci. USA 98, 8077–8082 (2001). · DOI
- Johansen, J. P. & Fields, H. L. Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nature Neurosci. (in the press). · DOI
- Kavaliers, M. & Colwell, D. D. Sex differences in opioid and non-opioid mediated predator-induced analgesia in mice. Brain Res. 568, 173–177 (1991). · DOI
- Miczek, K. A. & Winslow, J. T. Analgesia and decrement in operant performance in socially defeated mice: selective cross-tolerance to morphine and antagonism by naltrexone. Psychopharmacology (Berl.) 92, 444–451 (1987). · DOI
- Bellgowan, P. S. F. & Helmstetter, F. J. The role of μ and κ-opioid receptors within the periaqueductal gray in the expression of conditional hypoalgesia. Brain Res. 791, 83–89 (1998). · DOI
- Helmstetter, F. J., Bellgowan, P. S. & Poore, L. H. Microinfusion of μ- but not δ- or κ-opioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex in pentobarbital-anesthetized rats. J. Pharmacol. Exp. Ther. 275, 381–388 (1995).
- Foo, H. & Helmstetter, F. J. Hypoalgesia elicited by a conditioned stimulus is blocked by a μ-, but not a δ- or a κ-opioid antagonist injected into the rostral ventromedial medulla. Pain 83, 427–431 (1999). · DOI
- Foo, H. & Helmstetter, F. J. Activation of κ-opioid receptors in the rostral ventromedial medulla blocks stress-induced antinociception. Neuroreport 11, 3349–3352 (2000). · DOI
- Blass, E., Fitzgerald, E. & Kehoe, P. Interactions between sucrose, pain and isolation distress. Pharmacol. Biochem. Behav. 26, 483–489 (1987). · DOI
- Bucher, H. U. et al. Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatr. Res. 38, 332–335 (1995). · DOI
- Dutta, R., Mukherjee, K. & Mathur, R. Effect of VMH lesion on sucrose-fed analgesia in formalin pain. Jpn J. Physiol. 51, 63–69 (2001). · DOI
- Dum, J. & Herz, A. Endorphinergic modulation of neural reward systems indicated by behavioral changes. Pharmacol. Biochem. Behav. 21, 259–266 (1984). The authors show that rats conditioned to expect sucrose when they are placed on a hot plate will show elevated escape thresholds. This analgesic effect is blocked by the opioid antagonist naloxone. · DOI
- Schmidt, B. L., Tambeli, C. H., Levine, J. D. & Gear, R. W. μ/δ Cooperativity and opposing κ-opioid effects in nucleus accumbens-mediated antinociception in the rat. Eur. J. Neurosci. 15, 861–868 (2002). · DOI
- Kelley, A. E. et al. Opioid modulation of taste hedonics within the ventral striatum. Physiol. Behav. 76, 365–377 (2002). · DOI
- Benedetti, F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64, 535–543 (1996). · DOI
- Grevert, P. & Goldstein, A. in Placebo: Theory, Research and Mechanisms (eds White, L., Tursky, B. & Shwartz, G. E.) 332–350 (The Guilford Press, New York, 1985).
- Price, D. D. et al. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83, 147–156 (1999). · DOI
- Montgomery, G. H. & Kirsch, I. Classical conditioning and the placebo effect. Pain 72, 107–113 (1997). · DOI · Paper page
- Amanzio, M. & Benedetti, F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J. Neurosci. 19, 484–494 (1999). · DOI · Paper page
- de la Fuente-Fernandez, R., Schulzer, M. & Stoessl, A. J. The placebo effect in neurological disorders. Lancet Neurol. 1, 85–91 (2002). · DOI · Paper page
- Petrovic, P., Kalso, E., Petersson, K. M. & Ingvar, M. Placebo and opioid analgesia — imaging a shared neuronal network. Science 295, 1737–1740 (2002). Using positron emission tomography, the authors show extensive overlap between brain areas that are activated by the short-acting MOR agonist remifentanyl and a placebo manipulation that produces analgesia. · DOI · Paper page
- Wager, T. D. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303, 1162–1167 (2004). · DOI · Paper page
- An, X., Bandler, R., Ongur, D. & Price, J. L. Prefrontal cortical projections to longitudinal columns in the midbrain periaqueductal gray in macaque monkeys. J. Comp. Neurol. 401, 455–479 (1998). · DOI · Paper page
- Kirsch, P. et al. Anticipation of reward in a nonaversive differential conditioning paradigm and the brain reward system: an event-related fMRI study. Neuroimage 20, 1086–1095 (2003). · DOI
- Shidara, M. & Richmond, B. J. Anterior cingulate: single neuronal signals related to degree of reward expectancy. Science 296, 1709–1711 (2002). · DOI
- Kunishio, K. & Haber, S. N. Primate cingulostriatal projection: limbic striatal versus sensorimotor striatal input. J. Comp. Neurol. 350, 337–356 (1994). · DOI
- Becerra, L., Breiter, H. C., Wise, R., Gonzalez, R. G. & Borsook, D. Reward circuitry activation by noxious thermal stimuli. Neuron 32, 927–946 (2001). · DOI
- Suzuki, R., Morcuende, S., Webber, M., Hunt, S. P. & Dickenson, A. H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nature Neurosci. 5, 1319–1326 (2002). · DOI
- Le Bars, D. in Serotonin and Pain (eds Osborne, N. M. & Hamon, M.) 171–226 (John Wiley, New York, 1988).
- Potrebic, S. B., Fields, H. L. & Mason, P. Serotonin immunoreactivity is contained in one physiological cell class in the rat rostral ventromedial medulla. J. Neurosci. 14, 1655–1665 (1994). Using in vivo intracellular recording, on, off and neutral cells were identified physiologically and filled with biocytin for later immunocytochemistry. Serotonin was only found in neutral cells. · DOI
- Marinelli, S., Vaughan, C. W., Schnell, S. A., Wessendorf, M. W. & Christie, M. J. Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J. Neurosci. 22, 10847–10855 (2002). The authors use a marker injected into the spinal cord and transported retrogradely to identify spinally projecting RVM neurons. They show that a significant number of spinally-projecting serotonergic neurons express functional μ- and κ-opioid receptors. · DOI
- Mason, P. & Gao, K. Raphe magnus serotonergic neurons tonically modulate nociceptive transmission. Pain Forum 7, 143–150 (1998). · DOI
- Huang, L. -Y. M. Tonic release of serotonin. Pain Forum 7, 151–154 (1998). · DOI
- Yaksh, T. L. & Wilson, P. R. Spinal serotonin system mediates antinociception. J. Pharmacol. Exp. Ther. 208, 446–453 (1979).
- Zhuo, M. & Gebhart, G. F. Spinal serotonin receptors mediate descending facilitation of a nociceptive reflex from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Brain Res. 550, 35–48 (1991). · DOI
- Calejesan, A. A., Chang, M. H. & Zhuo, M. Spinal serotonergic receptors meidate facilitation of a nociceptive reflex by subcutaneous formalin inejction into the hindpaw in rats. Brain Res. 798, 46–54 (1998). · DOI
- Green, G. M., Scarth, J. & Dickenson, A. An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT3 receptors in the anaesthetized rat. Pain 89, 81–88 (2000). · DOI
Cited by
Sorted by citations
Items 101–200 of 805
Placebo effects in laser-evoked pain potentials.
Wager, T., Matre, D., & Casey, K. (2006) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2006.01.007 · Cited by 149
“The theory is that cognitive expectations maintained in prefrontal cortex may activate the PAG, which has the capability to inhibit pain signals at the level of the spinal cord (e.g., Fields, 2004).”
BackgroundInfluentialNerve Injury-Induced Neuropathic Pain Causes Disinhibition of the Anterior Cingulate Cortex
Blom, S. M., Pfister, J.-P., Santello, M., Senn, W., & Nevian, T. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3667-13.2014 · Cited by 165
“The ACC also projects to the periaqueductal grey, an area that plays an important role in descending modulation of pain (Wyss and Sripanidkulchai 1984; Fields 2004).”
BackgroundPain-Related Anxiety-Like Behavior Requires CRF1 Receptors in the Amygdala
Ji, G., Fu, Y., Ruppert, K. A., & Neugebauer, V. (2007) · Molecular Pain · doi:10.1186/1744-8069-3-13 · Cited by 139
“The amygdala is also believed to be a key substrate of the reciprocal relationship between pain and affective states and disorders such as anxiety [3,10,12,13].”
BackgroundAtlas, L. Y., & Wager, T. D. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-44519-8_3 · Cited by 162
“…apparent in the pgACC/rACC and the periacqueductal gray, two brain regions that have been linked with endogenous opioid release in animal models (Fields 2000, 2004) and in prior studies of placebo analgesia in humans (Levine et al. 1978) (Eippert et al. 2009a; Wager et al. 2007b; Zubieta et al.…”
Becerra, L. R., Harter, K., González, R. G., & Borsook, D. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000221457.71536.e0 · Cited by 135
“We hypothesized that morphine should activate regions of the brain associated with each of its well described behavioral effects, including analgesia (4), reward/addiction (5), and sedation (6).”
BackgroundFunctional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits
Wang, D., Tawfik, V. L., Corder, G. F., Low, S. A., François, A., Basbaum, A. I., & Scherrer, G. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.002 · Cited by 159
“Opioids, such as morphine, are the mainstay for the treatment of moderate to severe pain (Fields, 2004).”
BackgroundFurther evidence for individual differences in placebo responding: An interactionist perspective
Geers, A. L., Kosbab, K., Helfer, S. G., Weiland, P. E., & Wellman, J. A. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.12.005 · Cited by 134
“For example, recent studies have clarified the involvement of opioid and nonopioid mechanisms in placebo analgesia; the relationship between placebos, conditioning, and immunosuppression; and neuroanatomy substrates associated with placebo responding [7–11].”
BackgroundWhat’s in a word? How instructions, suggestions, and social information change pain and emotion
Koban, L., Jepma, M., Geuter, S., & Wager, T. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.014 · Cited by 166
Tinnitus: perspectives from human neuroimaging
Elgoyhen, A., Langguth, B., Ridder, D. D., & Vanneste, S. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4039 · Cited by 134
Yelle, M. D., Oshiro, Y., Kraft, R., & Coghill, R. C. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4648-08.2009 · Cited by 132
“In general, their primary function has been viewed primarily as gain control, reducing the rostral flow of nociceptive information to facilitate escape, feeding, or mating in the presence of pain or to amplify nociceptive information during disease or injury (Millan, 2002; Fields, 2004).”
BackgroundFormisano, L., Noh, K.-M., Miyawaki, T., Mashiko, T., Bennett, M. V. L., & Zukin, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611704104 · Cited by 132
Identification of discrete functional subregions of the human periaqueductal gray
Satpute, A. B., Wager, T. D., Cohen-Adad, J., Bianciardi, M., Choi, J.-K., Buhle, J. T., Wald, L. L., & Barrett, L. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306095110 · Cited by 131
“affective lives? Neurosci Biobehav Rev 35(9):1791–1804.”
BackgroundInfluentialWanigasekera, V., Lee, M., Rogers, R., Kong, Y., Leknes, S., Andersson, J., & Tracey, I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120201109 · Cited by 136
“McGaraughty S, Heinricher MM (2002) Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity.”
BackgroundInfluentialReward‐aversion circuitry in analgesia and pain: Implications for psychiatric disorders
Borsook, D., Becerra, L. R., Carlezon, W. A., Shaw, M. E., Renshaw, P. F., Elman, I., & Levine, J. D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.12.005 · Cited by 124
“The notion that analgesia is rewarding is supported by several lines of evidence: termination of a painful stimulus can be rewarding (Seymour et al., 2005) and, depending on the state of the organism, endogenous opioids can modulate reward systems (reviewed in (Fields, 2004)).”
BackgroundInfluentialOudenhove, L. V., Vandenberghe, J. U., Dupont, P. J., Geeraerts, B., Vos, R. D., Dirix, S., Bormans, G. M., Vanderghinste, D., Laere, K. V., Demyttenaere, K., et al. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.39 · Cited by 137
Idiopathic Cystitis in Domestic Cats—Beyond the Lower Urinary Tract
Buffington, C. A. T. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2011.0732.x · Cited by 137
“Thus, the effects of the emotional state of the animal may modulate perceived sensations from peripheral organs, completing a loop that may be modulated by both central and peripheral neural activity.(143) Hormonal.”
Weibel, R., Reiss, D. J., Karchewski, L. A., Gardon, O., Matifas, A., Filliol, D., Becker, J. A. J., Wood, J. N., Kieffer, B. L., & Gavériaux‐Ruff, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074706 · Cited by 134
“Opioids also regulate descending inhibitory pain pathways by recruiting receptors in periacqueductal grey and rostral ventral medulla [5,6].”
BackgroundJi, G., & Neugebauer, V. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00135.2007 · Cited by 125
“4) The amygdala is emerging as a neuronal interface between pain and affective states and disorders such as anxiety (Fields 2004; Heinricher and McGaraughty 1999; Neugebauer et al. 2004; Neugebauer 2006; Pedersen et al. 2007; Rhudy and Meagher 2001).”
BackgroundInfluentialBelief or Need? Accounting for individual variations in the neurochemistry of the placebo effect
Zubieta, J.-K., Yau, W. W., Scott, D., & Stohler, C. S. (2005) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.08.006 · Cited by 113
State-dependent μ-opioid modulation of social motivation
Løseth, G. E., Ellingsen, D., & Leknes, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00430 · Cited by 128
“High activity in these regions also predicted lower levels of sadness and feelings of rejection (Hsu et al., 2013), perhaps analogous to a coping mechanism for physical pain that is activated in stressful or threatening contexts (Fields, 2004).”
BackgroundSchröder, W., Lambert, D. G., Ko, M., & Koch, T. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12744 · Cited by 128
“In the RVM, OFF cells are tonically inhibited by ON cells via GABAergic mechanisms (Fields, 2004).”
Pharmacotherapy for Neuropathic Pain
Jackson, K. C. (2006) · Pain Practice · doi:10.1111/j.1533-2500.2006.00055.x · Cited by 75
Resting state connectivity correlates with drug and placebo response in fibromyalgia patients
Schmidt-Wilcke, T., Ichesco, E., Hampson, J. P., Kairys, A., Peltier, S., Harte, S., Clauw, D. J., & Harris, R. E. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2014.09.007 · Cited by 122
“That said, it needs to be acknowledged that most evidence stems from animal research (Fields, 2004) and that the precise mapping of these pathways in humans is currently unknown.”
Bruehl, S. P., Apkarian, A. V., Ballantyne, J. C., Berger, A. M., Borsook, D., Chen, W., Farrar, J. T., Haythornthwaite, J. A., Horn, S. D., Iadarola, M. J., et al. (2013) · Journal of Pain · doi:10.1016/j.jpain.2012.10.016 · Cited by 114
“These differences in opioid receptor availability in turn would likely influence responses to opioid analgesics.(38)”
The Use of DREADDs to Deconstruct Behavior
Whissell, P. D., Tohyama, S., & Martin, L. J. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00070 · Cited by 143
“Descending modulatory pathways can also facilitate pain perception in certain cases (Fields, 2004).”
BackgroundUnmasking the mysteries of the habenula in pain and analgesia
Shelton, L., Becerra, L. R., & Borsook, D. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.004 · Cited by 134
“Both serotonergic and dopaminergic systems have important roles in pain processing – including pain modulation (serotonin) (Fields, 2004; Benarroch, 2008) and”
Derbyshire, S. W. G., & Osborn, J. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.032 · Cited by 107
“Two types of neuron in the RVM, known as on and off cells, have been described as facilitating or inhibiting nociceptive transmission (Fields, 2004).”
Endogenous opioids mediate left dorsolateral prefrontal cortex rTMS-induced analgesia
Taylor, J. J., Borckardt, J. J., & George, M. S. (2012) · Pain · doi:10.1016/j.pain.2012.02.030 · Cited by 112
“The periaqueductal gray (PAG) and rostral ventromedial medulla (RVM) are critical components of a supraspinal opioidergic circuit (SOC) that modulates pain, the subjective experience frequently linked to nociception [6,7,33,49].”
BackgroundIdentifying local and descending inputs for primary sensory neurons
Zhang, Y., Zhao, S., Rodriguez, E., Takatoh, J., Han, B.-X., Zhou, X., & Wang, F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81156 · Cited by 138
“Furthermore, a previous study had discovered that RVM pronociceptive ON-cells express the μ-opioid receptor (MOR) (40).”
BackgroundInfluentialPlacebo improves pleasure and pain through opposite modulation of sensory processing
Ellingsen, D., Wessberg, J., Eikemo, M., Liljencrantz, J., Endestad, T., Olausson, H., & Leknes, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305050110 · Cited by 112
“This influence of vmPFC–PAG coupling on sensory processing may potentially reflect a descending modulatory mechanism acting at the spinal cord level, facilitating “positive” touch signals and suppressing nociceptive signals (7, 41).”
BackgroundDescending Control Mechanisms and Chronic Pain
Chen, Q., & Heinricher, M. M. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0813-1 · Cited by 137
Chen, T., Koga, K., Descalzi, G., Qiu, S., Wang, J., Zhang, L.-S., Zhang, Z.-J., He, X.-B., Qin, X., Xu, F., et al. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-33 · Cited by 117
μ-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons
Zhu, W. J., & Pan, Z. Z. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.004 · Cited by 110
Neurovascular mechanisms of migraine and cluster headache
Hoffmann, J., Baca, S. M., & Akerman, S. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17733655 · Cited by 138
Stein, N., Sprenger, C., Scholz, J., Wiech, K., & Bingel, U. (2012) · Pain · doi:10.1016/j.pain.2012.07.010 · Cited by 120
“Placebo analgesia requires the dynamic, context-dependent communication between cortical and subcortical structures known to be involved in descending pain inhibition [25,44].”
BackgroundPeciña, M., Sikora, M., Avery, E. T., Heffernan, J., Peciña, S., Mickey, B. J., & Zubieta, J.-K. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.08.427 · Cited by 125
“Placebo treatments in humans were initially hypothesized to be associated with the activity of mesolimbic DA cells during reward anticipation and their capacity to adapt to environmental information (Fields, 2004; Irizarry and Licinio, 2005).”
Benedetti, F., Thoen, W., Blanchard, C., Vighetti, S., & Arduino, C. (2012) · Pain · doi:10.1016/j.pain.2012.11.007 · Cited by 109
“Indeed, one of the main challenges of these endogenous systems is to understand their function and meaning [12].”
BackgroundMapping pain activation and connectivity of the human habenula
Shelton, L., Pendse, G., Maleki, N., Moulton, E. A., Lebel, A., Becerra, L. R., & Borsook, D. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00012.2012 · Cited by 128
Behavioral choice by presynaptic inhibition of tactile sensory terminals
Gaudry, Q., & Kristan, W. B. (2009) · Nature Neuroscience · doi:10.1038/nn.2400 · Cited by 108
Inflammatory pain is enhanced in delta opioid receptor‐knockout mice
Gavériaux‐Ruff, C., Karchewski, L. A., Hever, X. C., Matifas, A., & Kieffer, B. L. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06223.x · Cited by 116
“Chronic inflammation alters supraspinal pain-controlling sites (Przewlocki & Przewlocka, 2001; Tsuruoka et al., 2003) and activates descending opioidergic paincontrolling pathways (Fraser et al., 2000; Fields, 2004), which in turn impacts on pain perception.”
BackgroundInfluentialVariability in placebo analgesia and the role of fear of pain—an ERP study
Lyby, P. S., Aslaksen, P. M., & Flaten, M. A. (2011) · Pain · doi:10.1016/j.pain.2011.07.010 · Cited by 110
“It also means that both systems can be activated at the same time to varying degrees, and by implication, that the total inhibitory effect of opioids depends on the level of facilitatory influence [14].”
BackgroundJi, G., & Neugebauer, V. (2008) · Journal of Neurophysiology · doi:10.1152/jn.01148.2007 · Cited by 105
Tu, Y., Fang, J., Cao, J., Wang, Z., Park, J., Jorgenson, K., Lang, C., Liu, J., Zhang, G., Zhao, Y., et al. (2018) · Brain stimulation · doi:10.1016/j.brs.2018.01.006 · Cited by 104
Acupuncture modulates the abnormal brainstem activity in migraine without aura patients
Li, Z., Zeng, F., Yin, T., Lan, L., Makris, N., Jorgenson, K., Guo, T., Wu, F., Gao, Y., Dong, M., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.05.013 · Cited by 107
“RVM is a key region of the descending pain modulatory system (Millan, 2002; Fields, 2004; Kong et al., 2010), while TCC comprises the second-order neurons of the trigeminovascular nociceptive pathway.”
Placebo mechanisms across different conditions: from the clinical setting to physical performance
Pollo, A., Carlino, E., & Benedetti, F. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0381 · Cited by 99
Zhang, B., Jung, M., Tu, Y., Gollub, R. L., Lang, C., Ortiz, A., Park, J., Wilson, G., Gerber, J. A., Mawla, I., et al. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.02.021 · Cited by 106
Placebo analgesia: findings from brain imaging studies and emerging hypotheses
Kong, J., Kaptchuk, T. J., Polich, G., Kirsch, I., & Gollub, R. L. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.3-4.173 · Cited by 97
Brain Circuits Mediating Opposing Effects on Emotion and Pain
Cai, Y., Wang, W., Paulucci-Holthauzen, A. A., & Pan, Z. Z. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2780-17.2018 · Cited by 120
“Stimulation of BLA–CeA projection induces reward-like effect As pain causes aversive and unpleasant experience, pain inhibition is rewarding by inducing negative reinforcement (Fields, 2004).”
BackgroundCerebral interactions of pain and reward and their relevance for chronic pain
Becker, S., Gandhi, W., & Schweinhardt, P. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.013 · Cited by 103
Li, Z., Lü, Y.-F., Li, C.-L., Wang, Y., Sun, W., He, T., Chen, X.-F., Wang, X., & Chen, J. (2014) · Pain · doi:10.1016/j.pain.2014.03.019 · Cited by 105
“0 through the descending pathway from the rostroventral medulla [23,44].”
Kavaliers, M., Colwell, D. D., & Choleris, E. (2005) · Behavioral Ecology and Sociobiology · doi:10.1007/s00265-004-0896-0 · Cited by 102
“They serve to shift the motivational state of individuals towards the display of behaviors associated with coping with either actual or potential threats and away from the expression of nondefensive behaviors (Kavaliers and Choleris 2001; Fields 2004 ).”
BackgroundSynergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists
Grenald, S. A., Young, M. A., Wang, Y., Ossipov, M. H., Ibrahim, M. M., Largent-Milnes, T. M., & Vanderah, T. W. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.008 · Cited by 97
“, 2007) coupled with morphine's well-characterized ability to inhibit nociceptive signaling (Fields, 2004; McCabe et al., 2014).”
BackgroundSprenger, C., Finsterbusch, J., & Büchel, C. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4897-14.2015 · Cited by 92
“The mutual interplay between bottom-up and top-down signaling therefore represents a fundamental dimension in pain processing (Fields, 2004; Heinricher et al., 2009).”
BackgroundResultInfluentialPain perception and electromagnetic fields
Seppia, C. D., Ghione, S., Luschi, P., Ossenkopp, K., Choleris, E., & Kavaliers, M. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.01.003 · Cited by 90
“In these various contexts the induction of analgesia facilitates the expression of behaviors appropriate to particular situations (e.g. escape from predators, ingestion of food) and the inhibition of inappropriate behaviors and responses (Fields, 2004).”
BackgroundInfluentialMolecular mechanisms of placebo responses in humans
Peciña, M., & Zubieta, J.-K. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.164 · Cited by 103
Blockade of Endogenous Opioid Neurotransmission Enhances Acquisition of Conditioned Fear in Humans
Eippert, F., Bingel, U., Schoell, E. D., Yacubian, J., & Büchel, C. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5336-07.2008 · Cited by 100
“We therefore investigated whether the control group would show enhanced processing in a network implicated in descending pain control (Harris, 1996; Bingel et al., 2006) comprising the rACC, the amygdala, the PAG, and the RVM. Critically, if this network is indeed opioidergic and engaged by conditioning, then (1) proc…”
ResultInfluentialOptogenetic activation of brainstem serotonergic neurons induces persistent pain sensitization
Cai, Y.-Q., Wang, W., Hou, Y.-Y., & Pan, Z.-Z. Z. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-70 · Cited by 94
“The rostral ventromedial medulla (RVM), consisting of the nucleus raphe magnus (NRM), nucleus reticularis gigantocellularis and gigantocellularis pars alpha, is a key brainstem structure that relays processed information of pain from higher brain sites and exerts powerful descending modulation of spinal pain transmiss…”
BackgroundInfluentialRole of delivery and trafficking of δ-opioid peptide receptors in opioid analgesia and tolerance
Zhang, X., Bao, L., & Guan, J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.04.005 · Cited by 95
“However, in most cases, DOP-receptor-selective agonists produce only weak analgesic effects [ 9 ,41].”
BackgroundcAMP-Mediated Mechanisms for Pain Sensitization during Opioid Withdrawal
Bie, B., Peng, Y., Zhang, Y., & Pan, Z. Z. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5010-04.2005 · Cited by 92
“…morphine on AC expression levels and, consequently, on cAMP-mediated synaptic actions and pain behaviors, focusing on neurons in the nucleus raphe magnus (NRM), a brainstem site critically involved in opioid modulation of pain transmission in the spinal cord (Scholz and Woolf, 2002; Fields, 2004).”
InfluentialMechanisms of the placebo response
Benedetti, F., & Amanzio, M. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.01.006 · Cited by 93
Benarroch, E. E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182662098 · Cited by 152
Is serotonin hyperalgesic or analgesic?
Sommer, C. (2006) · Current pain and headache reports · doi:10.1007/s11916-006-0020-4 · Cited by 92
Liu, J., Chen, L., Tu, Y., Chen, X., Hu, K., Tu, Y., Lin, M., Xie, G., Chen, S., Huang, J., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.193 · Cited by 101
An Opiate Cocktail that Reduces Morphine Tolerance and Dependence
Li, H., & Whistler, J. L. (2005) · Current Biology · doi:10.1016/j.cub.2005.04.052 · Cited by 84
López-Canúl, M., Palazzo, E., Dominguez-Lopez, S., Luongo, L., Lacoste, B., Comai, S., Angeloni, D., Fraschini, F., Boccella, S., Spadoni, G., et al. (2015) · Pain · doi:10.1097/01.j.pain.0000460311.71572.5f · Cited by 89
“administration of opioids or cannabinoids, which are able to inhibit nociception, inhibits ON cells and increases OFF cells activity.(12,21,23,28) Thus, changes in ON and OFF cells activity are predictive of pain response modulation for putative analgesic drugs.”
Functional brain imaging of gastrointestinal sensation in health and disease
Oudenhove, L. V. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i25.3438 · Cited by 85
McNally, G. P., & Cole, S. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.2.313 · Cited by 94
“-opioid receptor activation of descending pain control circuits depends on opioid inhibition of GABAergic neurotransmission within the PAG (Fields, 2004).”
BackgroundMuscle Pain: Understanding the Mechanisms
Mense, S., & Gerwin, R. D. (2010) · Springer eBooks · doi:10.1007/978-3-540-85021-2 · Cited by 120
“The PAG in the mesencephalon – one of the main supraspinal centers for the processing of nociceptive impulses from muscle – is also the site of origin of descending pain-modulating pathways (Fields 2004).”
BackgroundInhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain
Kostich, W. A., Hamman, B. D., Li, Y.-W., Naidu, S., Dandapani, K., Feng, J., Easton, A. E., Bourin, C., Baker, K. B., Allen, J., et al. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.235333 · Cited by 107
“The failure of opioid antagonists to inhibit AAK1 inhibitor antinociception shows that AAK1 antinociception does not use the opioid system, a major inhibitory pain pathway used by endogenous and exogenous antinociceptives (Fields, 2004).”
BackgroundZyloney, C. E., Jensen, K. B., Polich, G. R., Loiotile, R. E., Cheetham, A., LaViolette, P. S., Tu, P., Kaptchuk, T. J., Gollub, R. L., & Kong, J. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-80 · Cited by 82
“The PAG was chosen for analysis because: 1) it is well known that the PAG plays a role in pain modulation [48-52]; 2) PAG has been found to play an important role in acupuncture analgesia [53-55]; and 3) in a previous analysis conducted using this same data set, we found that fMRI signal change to calibrated heat pain…”
MethodKosek, E., Jensen, K. B., Lonsdorf, T. B., Schalling, M., & Ingvar, M. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-37 · Cited by 77
Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome
Mechling, A. E., Arefin, T., Lee, H.-L., Bienert, T., Reisert, M., Ben Hamida, S., Darcq, E., Ehrlich, A., Gaveriaux-Ruff, C., Parent, M. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601640113 · Cited by 80
“In addition, connectivity of PAG, which is a major opioid-sensitive pain-modulatory structure in both rodents (14, 22) and humans (23) and is engaged in aversive learning (24), appeared entirely remodeled in mutant mice (Fig.”
BackgroundThe FMRFamide-Like Peptide Family in Nematodes
Peymen, K., Watteyne, J., Frooninckx, L., Schoofs, L., & Beets, I. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00090 · Cited by 96
“The principle of circuit flexibility relying on connectivity modulation also extends to vertebrates as exemplified by stress-induced analgesia, an acute suppression of pain generated mediated by opioids (151, 157, 158).”
BackgroundThe effects of trauma on brain and body: A unifying role for the midbrain periaqueductal gray
Terpou, B. A., Harricharan, S., McKinnon, M. C., Frewen, P., Jetly, R., & Lanius, R. A. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24447 · Cited by 82
“…thought to receive projections from the hypothal‐ amus and the limbic forebrain, including from several regions of the frontal neocortex and amygdala (Campos & Guimarães, 2009; Fogaça, Aguiar, Moreira, & Guimarães, 2012; Lisboa, Resstel, Aguiar, & Guimarães, 2008; for a review, see Fields, 2004).”
BackgroundOpioidergic regulation of astroglial/neuronal proliferation: where are we now?
Sargeant, T. J., Miller, J. H., & Day, D. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05671.x · Cited by 69
“The classical opioid system modulates many different aspects of physiology but is most well known for its control of nociception (Fields 2004) and reward-related behavior (Nestler 2004).”
BackgroundJayathilake, N. J., Phan, T. T., Kim, J., Lee, K. P., & Park, J. M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01409-0 · Cited by 90
“This dysfunction also results in an imbalance between excitatory and inhibitory processes, exacer-bating chronic pain 44,45 .”
Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain
Bravo, L., Llorca-Torralba, M., Berrocoso, E., & Micó, J. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01268 · Cited by 89
Acupuncture modulates cortical thickness and functional connectivity in knee osteoarthritis patients
Chen, X., Spaeth, R. B., Retzepi, K., Ott, D., & Kong, J. (2014) · Scientific Reports · doi:10.1038/srep06482 · Cited by 76
Imaging Human Cerebral Pain Modulation by Dose-dependent Opioid Analgesia
Wagner, K. J., Sprenger, T., Kochs, E. F., Tölle, T. R., Valet, M., & Willoch, F. (2007) · Anesthesiology · doi:10.1097/00000542-200703000-00020 · Cited by 84
“Results of experiments using microinjections of -opioid receptor agonists whose analgesic effects were reversed by -opioid receptor antagonists implicate that the -opioid receptor and enkephalins, as endogenous agonists, play a fundamental role in this native endogenous pain control system.(21) Furthermore, the import…”
BackgroundXu, Y., Umar, M., Kırıkkaleli, D., Adebayo, T. S., & Altuntaş, M. (2022) · Gondwana Research · doi:10.1016/j.gr.2022.04.015 · Cited by 78
The amygdala, a relay station for switching on and off pain
Rouwette, T., Vanelderen, P., Roubos, E. W., Kozicz, T., & Vissers, K. C. P. (2011) · European Journal of Pain · doi:10.1002/j.1532-2149.2011.00071.x · Cited by 70
Géranton, S. M., Fratto, V., Tochiki, K. K., & Hunt, S. P. (2008) · Molecular Pain · doi:10.1186/1744-8069-4-35 · Cited by 74
“There is evidence for both inhibitory and facilitatory serotonergic and non-serotonergic inputs to the dorsal horn [2,10,38,39].”
Cell type-specific modulation of sensory and affective components of itch in the periaqueductal gray
Samineni, V. K., Grajales‐Reyes, J. G., Sundaram, S. S., Yoo, J. J., & Gereau, R. W. (2019) · Nature Communications · doi:10.1038/s41467-019-12316-0 · Cited by 87
Kong, J., Wang, Z., Leiser, J., Minicucci, D., Edwards, R. R., Kirsch, I., Wasan, A. D., Lang, C., Gerber, J. A., Yu, S., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.01.021 · Cited by 81
“the descending pain modulatory system (Eippert and Tracey, 2014; Fields, 2004; Jensen et al., 2012; Kong et al., 2013a; Kucyi et al., 2013; Tracey et al., 2002; Yu et al., 2014a), forming a core network with the PAG and rostral ventral medulla (RVM) (Kong et al.”
BackgroundThe effects of Beta-Endorphin: state change modification
Veening, J. G., & Barendregt, H. P. (2015) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-12-3 · Cited by 89
“Since acute painful stimuli also raise these CSF levels considerably [170,359,375,400,401], it is fully clear that the central release of β-END forms part of an antinociceptive system controlling pain [71,79,402,403].”
BackgroundEstrogenic involvement in social learning, social recognition and pathogen avoidance
Choleris, E., Clipperton‐Allen, A. E., Phan, A., Valsecchi, P., & Kavaliers, M. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.02.001 · Cited by 83
“potential threat, and is advantageous in situations in which a direct response to noxious stimuli might otherwise disrupt other adaptive behavioral responses [91].”
Zhao, Z.-Q., Gao, Y., Sun, Y.-G., Zhao, C., Gereau, R. W., & Chen, Z. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705740104 · Cited by 74
Nadal, X., La Porta, C., Andreea Bura, S., & Maldonado, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.077 · Cited by 76
Liu, Q., Su, L., Sun, C., Jiao, L., Miao, Y., Xu, M., Luo, R., Zuo, X., Zhou, R., Zheng, P., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101560 · Cited by 79
Brain‐bladder control network: The unsolved 21st century urological mystery
Kitta, T., Mitsui, T., Kanno, Y., Chiba, H., Moriya, K., & Shinohara, N. (2015) · International Journal of Urology · doi:10.1111/iju.12721 · Cited by 69
“It is now believed that the PAG receives direct projections from the hypothalamus and regions within the limbic forebrain, such as the ACC.(14,15) It seems likely that these PAG inputs might be the neural basis for forebrain access to the control of bladder emptying and maintenance of social continence.”
BackgroundInfluentialHossaini, M., Goos, J. A. C., Kohli, S. K., & Holstege, J. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035293 · Cited by 74
“The facilitatory effect of the RVM is exerted by the physiologically characterized ON-cells, while the inhibitory effect is mainly produced by the physiologically characterized OFF-cells [3,5,52,53].”
BackgroundValidity of acute and chronic tactile sensory testing after spinal cord injury in rats
Detloff, M. R., Clark, L. M., Hutchinson, K. J., Kloos, A., Fisher, L. C., & Basso, D. M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.07.009 · Cited by 73
“…processing level, including food distraction, stabilizes sensory perception in humans and animals by tempering hypervigilant behavior (Aminabadi et al., 2008; Casey and Morrow, 1983; Ford et al., 2008; Hoffman et al., 2008) and potentially modulating mu opioid receptors (Fields, 2004; Mason, 2005).”
Ballantyne, J. C., & Sullivan, M. D. (2017) · Pain · doi:10.1097/j.pain.0000000000001043 · Cited by 79
Deep brain stimulation of the periaqueductal gray releases endogenous opioids in humans
Sims-Williams, H. P., Matthews, J. C., Talbot, P. S., Love‐Jones, S., Brooks, J. C. W., Patel, N. K., & Pickering, A. E. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.08.038 · Cited by 79
“Given the known anatomical and functional connectivity between the PAG and the rostral-ventromedial medulla (Fields, 2004; Millan, 2002; Ossipov et al., 2010) (RVM) we performed an exploratory analysis of the change in [11C]DPN VT in the medulla and the nearby pons and cerebellum.”
BackgroundMethodG-Protein-Coupled Receptors in Adult Neurogenesis
Doze, V. A., & Perez, D. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004762 · Cited by 75
“The classic opioid receptor system modulates many different aspects of physiology but is most known for its control of nociception (Fields, 2004) and reward-related behavior (Nestler, 2004).”
BackgroundSynaptic Mechanism for Functional Synergism between δ- and μ-Opioid Receptors
Zhang, Z., & Pan, Z. Z. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5968-09.2010 · Cited by 79
“In contrast to MORs, DOR agonists have weak analgesic effects, which, as demonstrated by recent studies, was probably due to none to low levels of surface expression of functional DORs in brain and spinal neurons important in central pain-modulating circuits (Hurley and Hammond, 2000; Fields, 2004; Ma et al., 2006).”
BackgroundInfluentialUnique, common, and interacting cortical correlates of thirst and pain
Farrell, M. J., Egan, G. F., Zamarripa, F., Shade, R. E., Blair-West, J. R., Fox, P. T., & Denton, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511019103 · Cited by 76
Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability
Karjalainen, T., Tuominen, L. J., Manninen, S., Kalliokoski, K. K., Nuutila, P., Jääskeläinen, I. P., Hari, R., Sams, M. E., & Nummenmaa, L. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw044 · Cited by 76
MeCP2 Repression of G9a in Regulation of Pain and Morphine Reward
Zhang, Z., Tao, W., Hou, Y.-Y., Wang, W., Kenny, P. J., & Pan, Z. Z. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4194-13.2014 · Cited by 88
“Indeed, CeA mediates both drug reward-related positive emotional behaviors (Baxter and Murray, 2002; Gottfried et al., 2003; See et al., 2003) and negative emotional states of affective pain (Fields, 2004; Neugebauer et al., 2009).”
BackgroundInfluentialGroppetti, D., Pecile, A., Sacerdote, P., Bronzo, V., & Ravasio, G. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer199 · Cited by 70
Metadata
- Authors
- Fields, H.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Fields, Howard
- ORCID
- Fields, Howard
- Venue
- Nature Reviews Neuroscience
- Published
- 2004-07
- Volume
- 5
- Issue
- 7
- Pages
- 565-575
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2030751218
- Cited by
- 946
- References
- 0
- Citations by year
- 2026: 46 · 2025: 43 · 2024: 36 · 2023: 42 · 2022: 54 · 2021: 52 · 2020: 38 · 2019: 43 · 2018: 49 · 2017: 66 · 2016: 45 · 2015: 39 · 2014: 48 · 2013: 47 · 2012: 56
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- opioid analgesia, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, motivational states, aversive motivation, appetitive motivation, pain transmission, pain modulation, opioid use disorder, choice behavior
- MeSH terms
- Analgesics, Opioid, Animals, Behavior, Animal, Humans, Medulla Oblongata, Models, Neurological, Motivation, Opioid-Related Disorders, Neural Pathways, Neurons, Nociceptors, Pain, Receptors, Opioid, Reinforcement, Psychology, Serotonin, Synapses, Neural Networks, Computer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review